ZENERLY

Serial Number 87445606
606

Registration Progress

Application Filed
May 11, 2017
Under Examination
Oct 24, 2017
Approved for Publication
Aug 29, 2017
Published for Opposition
Aug 29, 2017
Registered

Basic Information

Serial Number
87445606
Filing Date
May 11, 2017
Published for Opposition
August 29, 2017
Abandonment Date
June 8, 2020
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jun 8, 2020
Classes
005

Rights Holder

Sage Therapeutics, Inc.

03
Address
215 First Street
Cambridge, MA 02142

Ownership History

Sage Therapeutics, Inc.

Original Applicant
03
Cambridge, MA

Sage Therapeutics, Inc.

Owner at Publication
03
Cambridge, MA

Legal Representation

Attorney
Steven A. Abreu

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

35 events
Date Code Type Description
Jun 8, 2020 ABN6 S ABANDONMENT - NO USE STATEMENT FILED
Jun 8, 2020 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Feb 10, 2020 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 5, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 3, 2019 EEXT I SOU TEAS EXTENSION RECEIVED
Oct 3, 2019 EXT4 S SOU EXTENSION 4 FILED
Oct 3, 2019 EX4G S SOU EXTENSION 4 GRANTED
Apr 24, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 22, 2019 EEXT I SOU TEAS EXTENSION RECEIVED
Apr 22, 2019 EXT3 S SOU EXTENSION 3 FILED
Apr 22, 2019 EX3G S SOU EXTENSION 3 GRANTED
Apr 8, 2019 DOCK D ASSIGNED TO EXAMINER
Oct 19, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 17, 2018 EEXT I SOU TEAS EXTENSION RECEIVED
Oct 17, 2018 EXT2 S SOU EXTENSION 2 FILED
Oct 17, 2018 EX2G S SOU EXTENSION 2 GRANTED
Apr 20, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 18, 2018 EEXT I SOU TEAS EXTENSION RECEIVED
Apr 18, 2018 EXT1 S SOU EXTENSION 1 FILED
Apr 18, 2018 EX1G S SOU EXTENSION 1 GRANTED
Oct 24, 2017 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 29, 2017 PUBO A PUBLISHED FOR OPPOSITION
Aug 29, 2017 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 9, 2017 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 25, 2017 ALIE A ASSIGNED TO LIE
Jul 3, 2017 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 13, 2017 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 12, 2017 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 12, 2017 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 6, 2017 CPRA R PRIORITY ACTION WRITTEN
Jun 6, 2017 GPRA F PRIORITY ACTION E-MAILED
Jun 6, 2017 GPRN O NOTIFICATION OF PRIORITY ACTION E-MAILED
Jun 5, 2017 DOCK D ASSIGNED TO EXAMINER
May 16, 2017 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 15, 2017 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
pharmaceutical preparations for treating diseases and disorders of the central nervous system, epilepsy, and depression
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005